Nabriva Therapeutics plc
Nabriva Therapeutics plc (NBRVF) Revenue
Annual & quarterly revenue history · segment & region breakdown
NBRVF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsNabriva Therapeutics plc trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nabriva Therapeutics plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nabriva Therapeutics plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Nabriva Therapeutics plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NBRVF revenue · 4 questionsNBRVF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Nabriva Therapeutics plc SEC filings · GAAP · Nabriva Therapeutics plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026